Shift4 Payments FOUR 深 沪
已收盘 01-30 16:00:00 美东时间
59.04
-0.360
-0.61%
华盛通- 最 高60.37
- 今 开59.36
- 成交量 154.80万股
- 最 低 58.76
- 昨 收 59.40
- 总市值 40.63亿
- 52周最高 127.50
- 市盈率 静 19.47
- 换手率 0.00%
- 52周最低 58.44
- 委 比 -13.42%
- 总股本 6881.82万
- 历史最高 127.50
- 量 比 0.74
- 振 幅 2.71%
- 历史最低 29.39
- 每 手 1
- 风险率 14.71%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 潜在上涨空间31.6%！巴克莱上调台积电目标价至450美元；第一地平线全国银行获5家机构上调目标价
今日重点评级关注：Guggenheim：维持MBX Biosciences"买入"评级，目标价从77美元升至88美元；摩根士丹利：维持DraftKings"超配"评级，目标价从50美元升至53美元
01-20 10:26
Shift4 Payments (FOUR) Gets a Buy from Seaport Global
Seaport Global analyst Jeff Cantwell maintained a Buy rating on Shift4 Payments...
01-18 22:35
美股大行评级 | 英特尔、美光科技、SanDisk等获大行上调目标价；纽约梅隆银行获5家大行上调目标价
今日重点评级关注：HC Wainwright & Co.：维持Rezolve AI"买入"评级，目标价从10美元升至12美元；HC Wainwright & Co.：维持Largo"买入"评级，目标价从2.9美元升至3.1美元
01-15 16:10
Deep Dive Into Shift4 Payments Stock: Analyst Perspectives (19 Ratings)
Shift4 Payments (NYSE:FOUR) has been analyzed by 19 analysts in the last three ...
01-15 02:00
美股大行评级 | Medline获14家大行首予评级，最高目标价52美元；富国银行上调GOOGL目标价从268美元升至350美元
今日重点评级关注：HC Wainwright & Co.：维持Enlivex Therapeutics"买入"评级，目标价从7美元升至13美元；BTIG：维持Oruka Therapeutics"买入"评级，目标价从63美元升至73美元
01-13 10:18
Oppenheimer Maintains Outperform on Shift4 Payments, Lowers Price Target to $98
Oppenheimer analyst Rayna Kumar maintains Shift4 Payments (NYSE:FOUR) with a Outperform and lowers the price target from $112 to $98.
01-13 01:39
Trump's NASA Administrator Jared Isaacman Reaffirms Commitment To Mars, Artemis Mission: 'We're Gonna Build Nuclear Spaceships'
Jared Isaacman praises Trump's ambitious space policy including plans for a moon base and nuclear spaceships to reach Mars.
01-12 17:31
美股大行评级 | 潜在涨幅197.4%！奥麦罗制药获HC Wainwright升目标价至40美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持奥麦罗制药"买入"评级，目标价从20美元升至40美元；HC Wainwright & Co.：维持Cullinan Therapeutics"买入"评级，目标价从26美元升至27美元
01-09 20:22
Shift4 Payments Reprices Term Loan to Lower Interest
Shift4 Payments ( ($FOUR) ) just unveiled an announcement. On January 5, 2026, ...
01-06 06:26
Shift4 Payments: What Lies Ahead After Breakout Rejection
Shift4 Payments (NYSE:FOUR) is currently in Phase 7 of its 18-phase Adhishthana...
01-05 20:43
